Hemoperfusion with Seraph-100 in septic patients removes pathogens and improves clinical outcomes
Abstract Hemoperfusion (HP) represents a treatment option for sepsis. This study evaluated Seraph-100 in septic patients admitted to the intensive care unit (ICU) after cardiac surgery due to infective endocarditis (IE). Thirteen septic patients were enrolled and treated by Seraph-100 hemoperfusion....
Saved in:
| Main Authors: | Antonio Lacquaniti, Antonella Smeriglio, Fabrizio Ceresa, Susanna Campo, Daniele Caruso, Giuseppe Falliti, Erminia La Camera, Francesco Patané, Domenico Trombetta, Paolo Monardo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-01280-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seraphic Gender in “Doktor Serafikus” by V. Domontovych
by: Yuliia Karpets
Published: (2024-12-01) -
Extracorporeal therapies in sepsis: a comprehensive review of the Selective Cytopheretic Device, Polymyxin B and Seraph cartridges
by: Lucas Yessayan, et al.
Published: (2025-12-01) -
Fabrication of nanodiamonds/polyaniline nanocomposite for bilirubin adsorption in hemoperfusion
by: Futao Wang, et al.
Published: (2024-12-01) -
Clinical observation of hemoperfusion combined with hemofiltration dialysis in the treatment of septic shock with acute kidney injury
by: JIANG Zhong-yang, et al.
Published: (2019-01-01) -
Acute Kidney Injury, Renal Replacement Therapy, and Extracorporeal Membrane Oxygenation Treatment During the COVID-19 Pandemic: Single-Center Experience
by: Fabrizio Ceresa, et al.
Published: (2025-01-01)